Norepinephrine transporter occupancy by nortriptyline in patients with depression: a positron emission tomography study with (S,S)-[18F]FMeNER-D2-Reference-Cited by-同舟云学术

Norepinephrine transporter occupancy by nortriptyline in patients with depression: a positron emission tomography study with (S,S)-[18F]FMeNER-D2

Published:2013-12-18 Issue:04 Volume:17 Page:553-560
ISSN:1461-1457
Container-title:The International Journal of Neuropsychopharmacology
language:en
Short-container-title:Int. J. Neuropsychopharm.

Author:

Takano Harumasa,Arakawa Ryosuke,Nogami Tsuyoshi,Suzuki Masayuki,Nagashima Tomohisa,Fujiwara Hironobu,Kimura Yasuyuki,Kodaka Fumitoshi,Takahata Keisuke,Shimada Hitoshi,Murakami Yoshitaka,Tateno Amane,Yamada Makiko,Ito Hiroshi,Kawamura Kazunori,Zhang Ming-Rong,Takahashi Hidehiko,Kato Motoichiro,Okubo Yoshiro,Suhara Tetsuya

Publisher

Oxford University Press (OUP)

Subject

Pharmacology (medical),Psychiatry and Mental health,Pharmacology

Link

http://academic.oup.com/ijnp/article-pdf/17/4/553/1811593/17-4-553.pdf

Reference56 articles.

1. Occupancy of serotonin and norepinephrine transporter by milnacipran in patients with major depressive disorder: a positron emission tomography study with [11C]DASB and (S,S)-[18F]FMeNER-D2

2. Relationship of free nortriptyline levels to therapeutic response

3. Nortriptyline for Treatment-Resistant Depression

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Safe Deprescribing of Antidepressants;The Maudsley Deprescribing Guidelines – Antidepressants, Benzodiazepines, Gabapentinoids and Z‐drugs;2024-08-30

2. Update Lessons from PET Imaging Part II: A Systematic Critical Review on Therapeutic Plasma Concentrations of Antidepressants;Therapeutic Drug Monitoring;2024-01-24

3. Precision Medicine in Antidepressants Treatment;Precision Medicine;2023

4. Phosphatidylinositol 4,5-bisphosphate (PIP2) facilitates norepinephrine transporter dimerization and modulates substrate efflux;Communications Biology;2022-11-17

5. Differential Potency of Venlafaxine, Paroxetine, and Atomoxetine to Inhibit Serotonin and Norepinephrine Reuptake in Patients With Major Depressive Disorder;International Journal of Neuropsychopharmacology;2021-12-27